winter
season
nasopharyng
aspir
bronchoalveolar
lavag
sampl
patient
pediatr
adult
includ
lung
transplant
recipi
admit
hospit
acut
respiratori
tract
infect
examin
rapid
diagnosi
respiratori
virus
two
diagnost
approach
immunolog
use
specif
monoclon
antibodi
mab
molecular
use
specif
revers
transcript
rt
pcr
assay
method
detect
influenza
virus
b
human
parainfluenza
viru
type
human
respiratori
syncyti
viru
hrsv
type
b
human
adenovirus
addit
human
coronaviru
hcov
group
ii
well
new
human
metapneumoviru
hmpv
type
b
search
rtpcr
alon
result
obtain
method
ad
overal
percentag
patient
posit
least
one
respiratori
viru
peak
involv
patient
pediatr
adult
patient
neg
respiratori
viru
test
common
circul
viru
hrsv
infect
patient
type
type
b
strain
follow
hmpv
infect
patient
type
type
b
strain
coinfect
two
respiratori
virus
interest
patient
infect
hrsv
associ
anoth
respiratori
viru
great
major
infect
children
hrsv
hmpv
associ
lower
respiratori
tract
infect
lung
transplant
recipi
virus
present
bronchoalveolar
lavag
appear
associ
frequent
lower
respiratori
tract
infect
conclus
combin
immunolog
molecular
assay
sensit
approach
diagnosi
respiratori
viral
infect
infect
caus
less
investig
hcov
hmpv
repres
fair
proport
respiratori
infect
three
decad
ago
diagnosi
respiratori
viru
infect
requir
viru
isol
identif
embryon
hen
egg
cell
cultur
procedur
cumbersom
timeconsum
time
rapid
diagnosi
respiratori
viru
infect
cell
respiratori
tract
start
use
immunofluoresc
crossabsorb
anim
immun
sera
gardner
mc
quillin
monoclon
antibodi
mab
specif
differ
convent
respiratori
virus
becam
avail
thu
render
rapid
diagnosi
respiratori
tract
infect
nasopharyng
aspir
reliabl
stout
et
al
navarromari
et
al
fong
et
al
parallel
new
cell
cultur
system
increas
suscept
respiratori
virus
identifi
addit
primari
monkey
kidney
cell
cultur
thu
madindarbi
canin
kidney
mdck
cell
found
highli
suscept
influenza
virus
b
human
parainfluenza
virus
frank
et
al
shih
et
al
human
lung
carcinoma
cell
human
adenovirus
wood
young
smith
et
al
mink
lung
epitheli
cell
sever
influenza
virus
b
well
respiratori
virus
huang
turchek
thu
moment
fluoresc
mab
appropri
cell
cultur
system
includ
mix
cell
cultur
huang
turchek
wide
use
optim
detect
respiratori
virus
nasopharyng
secret
percival
et
al
navarromari
et
al
shih
et
al
zavattoni
et
al
recent
polymeras
chain
reaction
pcr
revers
transcriptasepcr
rtpcr
contribut
substanti
rapid
molecular
diagnosi
acut
respiratori
tract
infect
freymuth
et
al
fan
et
al
kehl
et
al
mullin
et
al
william
et
al
howev
whether
immunolog
molecular
approach
diagnosi
respiratori
tract
infect
consid
complementari
altern
one
two
techniqu
costeffect
remain
defin
addit
difficulti
viru
isol
cell
cultur
propag
convent
human
respiratori
coronavirus
hcov
lai
holm
well
human
metapneumovirus
hmpv
van
den
hoogen
et
al
consequ
lack
specif
reliabl
immunolog
reagent
limit
knowledg
circul
virus
geograph
area
investig
recent
molecular
method
final
rate
role
respiratori
viru
coinfect
respiratori
tract
patholog
remain
substanti
undefin
present
report
preval
pathogen
role
convent
virus
detect
immunolog
molecular
method
well
new
virus
detect
molecular
method
along
role
respiratori
viru
coinfect
investig
patient
popul
infant
adult
admit
hospit
acut
respiratori
infect
winterspr
season
octob
may
nasopharyng
aspir
pediatr
adult
patient
admit
hospit
episod
acut
respiratori
tract
infect
collect
examin
presenc
respiratori
virus
adult
patient
median
age
rang
year
lung
transplant
recipi
median
age
rang
year
bronchoalveolar
lavag
nasopharyng
aspir
sampl
taken
followup
upon
specimen
recept
follow
homogen
respiratori
sampl
divid
four
aliquot
one
use
immedi
direct
fluoresc
antibodi
stain
respiratori
cell
present
respiratori
secret
second
also
use
immedi
inocul
onto
cell
cultur
viru
isol
third
frozen
immedi
use
retrospect
molecular
assay
fourth
subaliquot
store
frozen
backup
sampl
futur
test
studi
sampl
examin
two
diagnost
approach
immunolog
molecular
immunolog
approach
adopt
prospect
base
use
mab
viru
identif
respiratori
secret
cell
inocul
cell
cultur
molecular
approach
adopt
retrospect
base
use
rtpcr
perform
directli
nucleic
acid
extract
respiratori
sampl
follow
revers
transcript
cdna
use
rtpcr
assay
well
repeat
test
virus
sought
method
influenza
virus
b
human
parainfluenza
virus
type
hpiv
human
respiratori
syncyti
viru
hrsv
human
adenovirus
hadv
addit
hcov
group
ii
well
hmpv
type
b
sought
rtpcr
hcov
group
sequenc
hmpv
type
sequenc
phylogenet
analysi
pool
mab
mabp
allow
simultan
detect
influenza
virus
b
hpiv
hrsv
hadv
well
individu
mab
identifi
singl
respiratori
virus
use
diagnosi
respiratori
viru
infect
direct
fluoresc
antibodi
stain
respiratori
cell
shell
vial
convent
cell
cultur
mabp
use
studi
simulfluor
respiratori
screen
chemicon
intern
inc
temecula
ca
contain
two
compon
one
compon
pool
fluoresceinconjug
mab
stain
bright
applegreen
influenza
virus
b
hpiv
hrsv
hadvinfect
cell
without
differenti
among
virus
compon
rhodamineconjug
mab
direct
hrsv
stain
yellowgold
hrsvinfect
cell
therebi
differenti
hrsv
respiratori
virus
fluoresceinconjug
mab
individu
respiratori
virus
obtain
commerci
sourc
chemicon
mab
hcov
chemicon
preliminarili
found
perform
satisfactorili
viru
identif
refer
strain
well
cell
respiratori
secret
posit
rtpcr
wherea
mab
hcov
abl
identifi
relev
prototyp
viru
mab
hmpv
found
avail
commerci
aliquot
respiratori
sampl
vortex
wash
repeatedli
direct
stain
respiratori
cell
report
previous
zavattoni
et
al
cell
pellet
suspend
ml
pb
cell
spot
onto
two
slide
slide
airdri
fix
aceton
first
slide
stain
mabp
two
spot
yellowgold
fluoresc
identifi
hrsvposit
cell
nasopharyng
aspir
applegreen
fluoresc
pattern
observ
second
slide
stain
individu
mab
except
mab
hrsv
slide
contain
epitheli
respiratori
cell
insuffici
number
epitheli
respiratori
cell
score
inadequ
slide
read
blindli
two
independ
observ
cell
obtain
atcc
rockvil
md
passag
respect
mixtur
mix
use
shell
vial
cultur
svc
ratio
mdck
cell
line
origin
obtain
sourc
subcultur
laboratori
cell
cultur
medium
emem
supplement
penicillinstreptomycin
glutamin
fetal
calf
serum
fc
nasopharyng
secret
sampl
process
immedi
upon
arriv
laboratori
aliquot
place
viral
transport
medium
consist
emem
supplement
penicillinstreptomycin
gentamycin
neomycin
mgml
fungizon
mg
ml
glutamin
fc
hr
prior
inocul
onto
cell
cultur
report
zavattoni
et
al
rule
ml
specimen
process
cell
cultur
inocul
onto
two
shell
vial
mdck
mix
cell
cultur
shell
vial
centrifug
rpm
min
incub
co
atmospher
hr
one
shell
vial
cell
type
fix
methanolaceton
stain
mabp
hrsv
identifi
yellowgold
pattern
fluoresc
detect
applegreen
pattern
fluoresc
observ
second
shell
vial
trypsin
cell
spot
onto
one
slide
eight
spot
stain
individu
mab
except
hrsv
final
identif
case
neg
result
hr
second
shell
vial
trypsin
cell
stain
hr
pi
type
cell
cultur
use
mdck
inocul
ml
specimen
two
tube
cell
line
incub
stationari
posit
observ
daili
cytopath
effect
day
report
zavattoni
et
al
cell
cultur
posit
neg
cytopath
effect
trypsin
wash
resuspend
pb
final
spot
onto
two
slide
first
slide
two
spot
second
slide
eight
spot
slide
airdri
fix
cold
aceton
first
slide
stain
mabp
spot
hrsv
identifi
presenc
yellowgreen
fluoresc
applegreen
fluoresc
observ
second
slide
stain
individu
fluoresc
mab
except
hrsv
case
neg
result
cultur
kept
observ
addit
week
optim
rtpcr
protocol
identif
respiratori
virus
develop
shown
tabl
primer
either
select
publish
protocol
origin
design
genbank
publish
viru
sequenc
refer
strain
propag
cell
cultur
viru
rna
dna
extract
use
nuclisen
isol
reagent
procedur
boxtel
nl
simultan
recoveri
nucleic
acid
submit
rtpcr
amplif
product
clone
plasmid
vector
ta
clone
kit
invitrogen
carlsbad
ca
achiev
quantit
standard
determin
analyt
sensit
rtpcr
assay
initi
experi
carri
accord
amplif
protocol
report
literatur
wide
variabl
analyt
sensit
individu
amplif
assay
observ
rang
input
copi
therefor
rtpcr
reaction
optim
detect
least
input
plasmid
copi
purpos
report
thermal
profil
reaction
mixtur
modifi
virus
new
set
primer
need
virus
tabl
rt
reaction
perform
final
volum
ml
use
ml
extract
nucleic
acid
pmol
random
exam
primer
new
england
biolab
beverli
u
superscript
tm
ii
rnase
hrevers
transcriptas
invitrogen
pcr
reaction
perform
final
volum
ml
use
ml
cdna
contain
ml
extract
dna
hadv
amplif
mm
trishcl
ph
mm
kcl
mm
mgcl
hrsv
hadv
hmpv
hcov
mm
mgcl
influenza
influenza
b
mm
mgcl
gelatin
mm
dntp
pmol
primer
u
taq
polymeras
roch
diagnost
gmbh
mannheim
germani
tabl
report
amplifi
fragment
target
gene
thermal
profil
cycl
number
appropri
relev
refer
viru
pcr
product
examin
agaros
gel
strain
hmpv
classifi
type
b
accord
recent
report
van
den
hoogen
et
al
viral
sequenc
hmpv
isol
patient
well
refer
strain
align
clustal
w
program
version
wherea
sequenc
similar
comparison
carri
megalign
program
dnastar
inc
madison
wi
distanc
pair
nucleotid
sequenc
calcul
use
dnadist
kimura
twoparamet
method
modul
philip
packag
version
felsenstein
depart
genet
univers
washington
seattl
wa
percent
genet
distanc
within
l
gene
calcul
two
major
branch
tree
philip
njplot
program
use
construct
phylogenet
tree
nucleotid
sequenc
mean
neighborjoin
method
distanc
matric
bootstrap
support
determin
resampl
sequenc
rtpcr
assay
use
studi
consist
singl
rt
reaction
follow
pcr
thermal
profil
specif
follow
group
virus
influenza
influenza
influenza
b
ii
iii
hrsv
subtyp
b
iv
hmpv
subtyp
b
v
hcov
group
ii
sole
dna
viru
amplifi
pcr
hadv
tabl
howev
genom
dna
unmodifi
rt
step
volum
rt
reaction
use
detect
virus
also
util
amplif
hadv
amplif
cell
infect
refer
respiratori
viru
strain
show
absenc
nonspecif
amplif
product
crossreact
addit
amplif
reaction
abl
detect
least
input
plasmid
copi
viru
fig
mab
appli
viru
detect
direct
fluoresc
stain
shell
vial
cultur
convent
cell
cultur
total
respiratori
secret
sampl
patient
examin
detect
convent
respiratori
virus
addit
bronchoalveolar
lavag
sampl
lung
transplant
recipi
examin
use
procedur
mention
hcov
hmpv
exclud
immunolog
detect
due
unavail
specif
mab
ratio
posit
examin
nasopharyng
aspir
sampl
method
direct
fluoresc
stain
shell
vial
cultur
convent
cell
cultur
thu
direct
fluoresc
stain
appear
slightli
sensit
shell
vial
cultur
convent
cell
cultur
exampl
direct
stain
respiratori
cell
posit
differ
respiratori
virus
nasopharyng
secret
given
figur
panel
fig
agaros
gel
detect
pcr
product
obtain
use
thermal
profil
follow
revers
transcript
viral
rna
extract
nasopharyng
aspir
no
pcr
lane
sampl
posit
lane
copi
plasmid
b
pcr
lane
sampl
posit
lane
copi
plasmid
c
pcr
lane
sampl
posit
lane
copi
plasmid
pcr
hadv
lane
sampl
posit
hadv
lane
copi
hadv
plasmid
mw
molecular
weight
marker
patient
stratifi
accord
convent
respiratori
virus
search
immunolog
molecular
method
thu
exclud
hcov
hmpv
found
posit
mab
rtpcr
mab
rtpcr
neg
method
tabl
ii
patient
overal
abil
method
detect
respiratori
viru
infect
interest
patient
hcov
hmpv
detect
rtpcr
includ
overal
evalu
patient
posit
one
respiratori
virus
number
rtpcrposit
patient
went
total
number
patient
posit
respiratori
virus
detail
comparison
immunolog
molecular
approach
diagnosi
individu
convent
respiratori
viru
infect
hospit
patient
doubl
infect
detect
show
posit
patient
viru
identifi
method
patient
discrep
result
found
posit
influenza
rtpcr
found
posit
hrsv
either
method
mab
rtpcr
patient
remain
consist
neg
tabl
iii
test
patient
rtpcr
hcov
hmpv
reveal
addit
patient
posit
hcov
one
two
strain
addit
patient
posit
hmpv
strain
belong
type
type
b
thu
total
number
patient
posit
singl
respiratori
viru
alreadi
mention
unavail
valuabl
mab
specif
two
group
virus
prevent
comparison
two
method
detect
two
respiratori
virus
among
patient
examin
case
coinfect
doubl
infect
detect
infant
adult
lung
transplant
recipi
case
number
report
tabl
iv
thu
seri
overal
number
patient
infect
one
two
respiratori
virus
mention
singl
case
coinfect
patient
detect
use
mab
wherea
mani
case
identifi
use
pcr
p
chi
squar
exact
fisher
test
report
tabl
iv
rtpcr
detect
coinfect
patient
no
mab
detect
doubl
infect
patient
patient
coinfect
mani
children
adult
infect
hrsv
associ
anoth
respiratori
viru
patient
coinfect
influenza
virus
b
five
adult
patient
coinfect
lower
respiratori
tract
infect
mani
three
lung
transplant
recipi
final
patient
coinfect
hrsv
hcov
patient
doubl
infect
hpiv
hmpv
type
whole
patient
posit
one
respiratori
virus
infant
adult
either
molecular
immunolog
detect
neg
detail
hrsv
type
type
b
strain
detect
patient
highli
circul
viru
follow
hmpv
patient
coinfect
patient
winter
season
octob
may
maxim
incid
respiratori
viral
infect
occur
januari
april
peak
march
fig
addit
distribut
respiratori
infect
within
first
year
age
show
infant
young
children
age
month
children
respiratori
infect
studi
mani
affect
hrsv
first
month
life
children
affect
hmpv
includ
rang
month
age
fig
major
agerel
peak
observ
respiratori
virus
within
first
year
age
data
seem
indic
trend
toward
earlier
predomin
pathogen
hrsv
earli
infanc
respect
hmpv
follow
sequenc
phylogenet
analysi
hmpv
strain
circul
winter
season
indic
simultan
presenc
two
major
type
b
hmpv
northern
itali
fig
among
patient
studi
singl
hmpv
infect
seven
posit
type
hmpv
five
type
b
patient
infect
type
hmpv
strain
five
infant
within
first
year
life
two
adult
five
infant
one
bronchiol
three
pneumonia
clinic
data
avail
one
two
adult
three
patient
two
infant
one
adult
singl
hcov
infect
follow
sequenc
two
patient
found
infect
strain
one
strain
infant
lower
respiratori
tract
infect
one
bronchiol
one
bronchopneumonia
wherea
adult
patient
lung
transplant
recipi
upper
respiratori
infect
addit
infant
cough
associ
doubl
infect
hcov
strain
hrsv
mani
hrsvinfect
children
lower
respiratori
tract
infect
includ
bronchiol
pneumonia
often
associ
xray
infiltr
similarli
hmpvinfect
children
four
type
three
type
b
strain
lower
respiratori
tract
infect
among
children
case
lower
respiratori
infect
detect
associ
hpiv
infect
hcov
infect
among
adult
patient
lower
respiratori
infect
influenza
viru
b
hmpv
hcov
two
lung
transplant
recipi
one
elderli
man
chronic
lung
diseas
group
coinfect
mani
nine
includ
hrsv
five
involv
children
lower
respiratori
infect
four
involv
adult
upper
respiratori
infect
lung
transplant
recipi
examin
posit
one
two
respiratori
virus
detail
bronchoalveolar
lavag
sampl
patient
nasopharyng
aspir
sampl
patient
posit
respiratori
virus
three
bronchoalveolar
lavageposit
sampl
allow
detect
two
hmpv
strain
type
b
one
coinfect
hpiv
hrsv
three
patient
lower
respiratori
infect
seven
nasopharyng
aspirateposit
sampl
reveal
presenc
hcov
influenza
virus
b
hrsv
coinfect
influenza
hrsv
coinfect
hpiv
hrsv
six
patient
respect
affect
upper
respiratori
infect
unfortun
simultan
sampl
site
taken
major
object
studi
investig
whether
diagnost
virolog
laboratori
molecular
approach
diagnosi
acut
respiratori
tract
infect
patient
popul
admit
hospit
conveni
immunolog
approach
strategi
may
provid
clinician
result
viral
assay
day
sampl
collect
howev
immunolog
approach
base
direct
stain
cell
nasopharyng
secret
thu
provid
result
within
hour
specimen
collect
also
viru
isol
shortterm
longterm
cell
cultur
follow
viru
identif
mab
thu
case
although
major
infect
patient
may
detect
direct
stain
fair
aliquot
acut
respiratori
infect
may
diagnos
follow
cell
cultur
ie
later
time
addit
read
directli
stain
slide
requir
expertis
immunofluoresc
dedic
personnel
interpret
result
handl
test
larg
number
sampl
feasibl
addit
nasopharyng
sampl
may
adequ
accord
protocol
influenza
virus
could
subtyp
hpiv
type
final
hcov
hmpv
could
detect
rtpcr
may
better
standard
allow
direct
type
respiratori
virus
obvious
pcr
perform
bear
risk
carryov
contamin
must
prevent
adopt
strict
contain
measur
separ
room
dispos
tip
adequ
educ
personnel
addit
multipl
neg
posit
pcr
control
includ
test
run
recent
sever
multiplex
pcr
rtpcr
system
develop
claim
even
greater
sensit
convent
viral
cultur
antigen
detect
method
gilbert
et
al
elli
et
al
freymuth
et
al
osiowi
coira
et
al
respect
decid
use
multiplex
pcr
amplifi
differ
respiratori
virus
achiev
maxim
sensit
instead
group
ident
thermal
profil
pcr
detect
respiratori
virus
belong
group
influenza
virus
hpiv
could
therefor
amplifi
amplif
run
specif
amplif
run
carri
virus
request
individu
thermal
profil
addit
influenza
virus
could
subtyp
hpiv
type
hcov
hmpv
detect
thu
complet
panel
import
respiratori
virus
could
sought
addit
pcr
effici
mab
detect
coinfect
studi
result
provid
molecular
immunolog
procedur
sampl
grossli
compar
number
discrep
result
restrict
minim
number
specimen
predomin
incid
hrsv
infect
follow
infect
caus
follow
group
virus
hmpv
ii
two
virus
coinfect
iii
influenza
virus
b
hpiv
iv
hcov
hadv
thu
observ
preval
differ
respiratori
viru
infect
studi
close
recent
report
among
children
hospit
acut
respiratori
ill
two
us
citi
mullin
et
al
predomin
incid
hrsv
infect
occur
januari
april
peak
march
addit
hrsv
appear
respons
great
major
respiratori
infect
first
month
life
hmpv
seem
play
major
role
subsequ
month
alreadi
report
other
van
den
hoogen
et
al
howev
conclus
immunolog
molecular
method
compar
sensit
appli
convent
respiratori
virus
detect
approach
diagnosi
extend
nonconvent
respiratori
virus
hmpv
hcov
mab
indic
reliabl
diagnost
use
yet
avail
yet
wide
test
molecular
method
may
use
apart
recent
identifi
hcov
respons
worldwid
outbreak
sever
acut
respiratori
syndrom
ksiazek
et
al
kuiken
et
al
lee
et
al
peiri
et
al
poutanen
et
al
two
distinct
antigen
group
hcov
first
detect
strain
prototyp
refer
prototyp
antigen
group
ii
respect
lai
holm
time
hcov
infect
could
diagnos
serolog
test
hcov
consid
respons
along
rhinovirus
common
cold
syndrom
mcintosh
et
al
hamr
recent
develop
molecular
method
allow
revisit
circul
spectrum
clinic
syndrom
caus
hcov
elsahli
et
al
falsey
et
al
includ
lower
respiratori
tract
infect
infant
well
elderli
immunocompromis
patient
pene
et
al
vabret
et
al
studi
document
confirm
sporad
associ
hcov
lower
respiratori
tract
infect
infant
transplant
patient
addit
use
molecular
method
hmpv
identifi
first
time
netherland
van
den
hoogen
et
al
shown
circul
canada
boivin
et
al
australia
nissen
et
al
unit
kingdom
stockton
et
al
franc
itali
maggi
et
al
hong
kong
peiri
et
al
unit
state
esper
et
al
mullin
et
al
south
africa
ijpma
et
al
hmpv
shown
caus
upper
lower
respiratori
tract
infect
latter
occur
frequent
infant
much
like
hrsv
immunocompromis
patient
boivin
et
al
pelleti
et
al
falsey
et
al
falsey
et
al
freymuth
et
al
circul
hmpv
among
infant
young
children
admit
hospit
acut
respiratori
infect
suggest
confirm
hmpv
may
associ
sever
lower
respiratori
tract
infect
accord
clinic
radiolog
pattern
alreadi
recogn
hrsv
genotyp
antigen
type
b
found
cocircul
winter
season
includ
subgenotyp
subtyp
van
den
hoogen
et
al
hmpv
circul
itali
alreadi
report
maggi
et
al
howev
origin
find
italian
studi
detect
hmpv
blood
infant
acut
respiratori
infect
find
await
confirm
laboratori
experi
hmpv
rna
could
detect
rtpcr
blood
six
infant
lower
respiratori
infect
associ
hmpv
acut
phase
infect
unpublish
data
whether
presenc
hmpv
blood
may
result
primari
infect
immunog
suscept
infant
remain
investig
recent
human
rotaviru
antigenemia
detect
blood
infant
acut
gastroenter
blutt
et
al
influenza
viru
rna
hadv
dna
detect
blood
patient
acut
encephalopathi
associ
influenza
viru
infect
steining
et
al
present
studi
mani
patient
diagnos
infect
either
hmpv
group
n
b
n
hcov
n
strain
rtpcr
thu
respiratori
virus
present
nasopharyng
secret
examin
procedur
detect
great
major
mab
pcr
molecular
method
contribut
significantli
increas
diagnost
rate
respiratori
viru
infect
detect
mab
furthermor
case
respiratori
viru
coinfect
diagnos
studi
mani
would
miss
without
use
rtpcr
result
may
somewhat
difficult
interpret
one
specul
cell
cultur
presenc
one
viru
may
interfer
growth
anoth
viru
hand
pcr
may
detect
nucleic
acid
sequenc
respiratori
sampl
belong
virus
unabl
grow
cell
cultur
howev
may
difficult
discrimin
whether
detect
two
virus
express
two
simultan
infect
occur
patient
one
viru
repres
residu
viru
previou
infect
detect
concomitantli
viru
caus
current
infect
viru
quantif
nasopharyng
aspir
might
help
discrimin
etiolog
role
two
virus
although
vari
among
differ
studi
coinfect
rate
gener
low
coira
et
al
van
den
hoogen
et
al
rang
van
den
hoogen
et
al
howev
whether
coinfect
repres
risk
factor
sever
diseas
uncertain
report
coinfect
hmpv
hrsv
may
worsen
prognosi
sever
respiratori
diseas
greensil
et
al
wherea
other
report
compar
rate
bronchopneumonia
children
infect
hmpv
alon
mix
infect
hmpv
anoth
respiratori
viru
maggi
et
al
role
respiratori
viru
coinfect
determin
sever
respiratori
infect
remain
substanti
determin
studi
coinfect
seem
worsen
prognosi
respiratori
infect
sever
coinfect
caus
hrsv
associ
respiratori
viru
sinc
hrsv
known
significantli
associ
lower
upper
respiratori
tract
infect
confirm
studi
appear
reason
attribut
sever
coinfect
involv
hrsv
infant
young
children
hrsv
rather
coinfect
viru
preliminari
conclus
studi
carri
prospect
immunolog
part
retrospect
molecular
part
suggest
diagnost
laboratori
receiv
limit
number
specimen
per
day
sampl
mab
may
use
detect
convent
virus
direct
stain
rtpcr
unconvent
virus
use
approach
virus
scarc
repres
respiratori
sampl
would
lost
would
major
impact
clinic
manag
respiratori
infect
howev
singl
procedur
use
diagnosi
acut
respiratori
infect
molecular
one
prefer
immunolog
approach
character
greater
overal
rapid
greater
costeffect
greater
sensit
detect
respiratori
virus
recent
report
show
superior
rtpcr
compar
convent
viral
cultur
diagnosi
acut
respiratori
infect
children
document
increas
yield
viral
identif
twofold
final
role
respiratori
virus
deserv
special
attent
solidorgan
recipi
particularli
lung
transplant
recipi
data
seem
suggest
preliminarili
patient
popul
presenc
respiratori
viru
bronchoalveolar
lavag
sampl
associ
frequent
lower
respiratori
tract
infect
thu
attribut
clinic
prognost
signific
detect
respiratori
viru
respiratori
secret
would
requir
bronchoalveolar
lavag
examin
lung
transplant
patient
popul
affect
lower
respiratori
tract
infect
conclus
immunolog
molecular
method
may
use
combin
achiev
highest
rate
identif
respiratori
infect
burden
respiratori
virus
may
caus
sever
lower
respiratori
tract
infect
infant
young
children
well
elderli
immunocompromis
host
pathogen
role
coinfect
remain
elucid
